Summary Cigarette smoking is associated with a reduction in the risk for endometrial cancer in postmenopausal women and it has been suggested that this is because smoking has an anti-oestrogenic effect. To investigate this, concentrations of oestrone, oestradiol and oestriol were measured in 24 h urine samples from 167 premenopausal women (53 smokers, 114 non-smokers) and 200 post-menopausal women (54 smokers, 146 non-smokers). Among premenopausal women there were no significant differences in oestrogen excretion between smokers and non-smokers. Among post-menopausal women, geometric mean excretion rates for oestrone and oestradiol did not differ significantly between groups, but oestriol excretion was 19% lower (95% confidence interval -34% to -1 %) in smokers than in non-smokers. This may partly explain the reduced risk for endometrial cancer among post-menopausal smokers.
In comparison with non-smokers, women who smoke have a lower risk of post-menopausal endometrial cancer, an earlier menopause and a higher incidence of osteoporosis, and it has been suggested that all these associations are consequences of an anti-oestrogenic effect of cigarette smoking (Baron, 1984) . The protective effect against post-menopausal endometrial cancer is substantial; for example, in a large population-based case-control study, Brinton et al. (1993) reported a relative risk of 0.4 in current smokers vs never smokers. Although this finding is of no direct value in preventing endometrial cancer, understanding of the mechanism involved is important and a number of studies have therefore investigated the association of cigarette smoking with sex hormones.
MacMahon et al. (1982) reported that premenopausal women smokers have reduced urinary excretion of oestrone, oestradiol and oestriol in the luteal phase (but not in the follicular phase) of the menstrual cycle and suggested that this might be caused by reduced oestrogen production. Subsequent investigations have shown that the relationship of cigarette smoking with steroid hormones is complex. Several studies have reported that smoking increases adrenal activity, resulting in increased serum concentrations of androstenedione and dehydroepiandrosterone sulphate, and of progesterone in post-menopausal women (and in the early follicular phase) (Friedman et al., 1987; Schlemmer et al., 1990; Zumoff et al., 1990; Cassidenti et al., 1992) . Smoking is not associated with serum concentrations of endogenous oestradiol among premenopausal or post-menopausal women (Friedman et al., 1987; Khaw et al., 1988; Longcope and Johnston, 1988; Cauley et al., 1989; Zumoff et al., 1990; Key et al., 1991; Berta et al., 1992; Cassidenti et al., 1992; Daniel et al., 1992) . These results suggest that the protective effect of smoking might be due to the increase in androgens and/or progesterone rather than due to a reduction in oestrogen exposure, although other investigations suggest that smoking does alter the metabolism of oestradiol. Serum concentrations of oestradiol are lower in smokers than in non-smokers among post-menopausal women taking oral oestrogen replacement therapy (Jensen et al., 1985) , and Michnovicz et al. (1986, 1988) reported that the proportion of estradiol metabolised by 2-hydroxylation is significantly higher in premenopausal women who smoke than in non-smokers and is accompanied by increased excretion of 2-hydroxyoestrone and decreased excretion of oestriol. Michnovicz et al. (1986, 1988) suggested that this decrease in the proportion of oestradiol catabolised to oestriol and increase in the proportion catabolised to 2-hydroxyoestrone would cause a net reduction in oestrogenic stimulation and could, therefore, explain the protective effect of smoking against endometrial cancer. However, other studies have failed to find significant differences in urinary oestrogen excretion between smokers and non-smokers among either premenopausal or postmenopausal women (Trichopoulos et al., 1987; Berta et al., 1992) . The purpose of the current study was to re-examine the possible association of cigarette smoking with urinary oestrogen excretion and, in particular, to test the hypothesis that smoking is associated with a reduction in the excretion of oestriol (Michnovicz et al., 1988) . We were unable to test the hypothesis of increased excretion of 2-hydroxyoestrone in smokers because our assay for this catecholoestrogen was not sufficiently sensitive. Between 1977 and 1984, approximately Assays Urine samples were considered to be incomplete if the 24 h urine volume was less than or equal to 633 ml, the lower limit of the 95% reference interval in 51 women studied by Bingham et al. (1988) . Aliquots of urine, identified by code numbers, were sent frozen to the University of Melbourne, where urinary concentrations of oestrone, oestradiol and oestriol were measured during 1989 and 1990 using a method involving spectrophotofluorimetry and internal radioactive standards (Brown, 1976) . Assay variation was assessed by including one quality control sample in each run of 12 samples. The mean values and coefficients of variation for this sample were: oestrone 9.8 jg I-', 11%; oestradiol 3.7 ,ug 11, 17%; oestriol 7.2 pg 1-', 14%. These coefficients of variation incorporate both within-assay and between-assay variability. Daily oestrogen excretion was calculated from the concentration in the urine and the volume of urine collected. The sensitivity of the method was sufficient to estimate concentrations as low as 0.1 ,ug 11, and no samples were below this limit.
Materials and methods

Subjects
To assess whether there was evidence for deterioration of the samples with long-term storage, we examined the association of total oestrogen excretion (oestrone + oestradiol + oestriol) with the year of urine collection in these samples plus other samples from the same cohort, which were collected later and were assayed for analysis in a nested case-control study of oestrogen excretion and breast cancer risk (Key et al., 1996) 
Results
Subject characteristics
Among premenopausal women, smokers were on average 0.9 years younger and 0.5 kg m-2 thinner than non-smokers (Table I) . Among post-menopausal women, smokers were on average 2.1 years younger, 0.8 years younger at menopause, and 0.3 kg m-2 thinnner than non-smokers (Table I) . Oestrogen excretion in premenopausal women Table II shows geometric mean urinary oestrogen excretion in non-smokers and smokers, grouped according to the stage of the menstrual cycle at which urine was collected.
Oestrogen excretion increased from the early follicular phase to the luteal phase. Geometric mean excretion of oestrone was 0-16% higher in smokers than in non-smokers, and geometric mean excretion of oestradiol was 4-15% higher in smokers than in non-smokers. Geometric mean excretion of oestriol was 30% higher in smokers than in non-smokers in the early follicular phase. but 5-22% lower in smokers in the later stages of the cycle. Table III shows geometric mean oestrogen excretion both by amount smoked and for all smokers, after adjusting for stage of cycle. There were no significant differences in oestrogen excretion between smokers and non-smokers.
Oestrogen excretion in post-menopausal women Adjusted geometric mean excretion rates for oestrone and oestradiol did not differ significantly between smokers and non-smokers. Geometric mean excretion of oestriol was 19% lower (95% confidence interval 34% to 1% lower) in smokers than in non-smokers (Table IV) . smokers than non-smokers. This change could be caused by increased catabolism of oestradiol through the alternative 2-hydroxylation pathway. as suggested by Michnovicz et al. (1986, 1988) from their study in premenopausal women, and might partly explain the protective effect of smoking against endometrial cancer. Trichopoulos et al. (1987) . however. reported no difference in oestriol excretion between postmenopausal smokers and non-smokers (mean difference between smokers and non-smokers +6%. 90% confidence interval -8% to +22%). but no information on the number of cigarettes smoked was given in this study.
We did not find any statistically significant differences in oestrogen excretion between smokers and non-smokers among premenopausal women. although there was a small (8%) reduction in oestriol excretion in smokers. MacMahon et al. (1982) reported similar excretion rates of oestrone. oestradiol and oestriol in smokers and non-smokers in the follicular phase, but about 30% lower excretion of all three oestrogens in smokers in the luteal phase, whereas Michnovicz et al. (1988) reported 31% lower excretion of oestriol in the follicular phase. However. in a large recent study. Berta et al. (1992) found no difference between smokers and non-smokers in luteal phase excretion of oestrone. oestradiol or oestriol. Overall, therefore. it is unclear whether smoking has an important effect on oestrogen excretion in premenopausal women.
Discussion
Epidemiiological studies have established that cigarette smoking reduces the nrsk of endometnral cancer in postmenopausal women. and investigation of the possible mechanism for this effect should increase our understanding of the aetiology of this disease. In the current study, the only statistically significant difference between study groups was the 19% lower excretion of oestriol in post-menopausal
